| ‘Dip and plateau pattern’ or ‘square root sign’ | 213 |
| Acute coronary syndrome | 122 |
| Acute myocardial infarction | 207 |
| Ambulation | 193 |
| Antioxidants | 150 |
| Aspirin | 94 |
| Atherosclerosis | 150, 158 |
| Atrial fibrillation | 19, 143, 185 |
| Atrial high-rate episodes (AHRE) | 49 |
| Autonomic nervous system | 49 |
| Balloon angioplasty | 61 |
| Benign heart tumors | 1 |
| Cardiac disease | 39 |
| Cardiac ischemia | 19 |
| Cardiac output | 19 |
| Cardiac resynchronization therapy | 9 |
| Cardiology | 169 |
| Cardiometabolic disorders | 76 |
| Carotid artery stenosis | 179 |
| Carotid artery stenting | 200 |
| Carotid endarterectomy | 179 |
| Carotid extra-media thickness | 53 |
| Carotid intima-media thickness | 53 |
| Central venous catheter | 130 |
| Cervical plexus block | 185 |
| Clopidogrel | 94 |
| Coarctation of the aorta | 61 |
| Collateral vessel | 27 |
| Coronary artery calcium score | 158 |
| Coronary artery disease | 27, 53, 76, 158 |
| Coronary artery disease risk factor | 27 |
| Coronary slow flow | 113 |
| COVID-19 | 143, 169 |
| COVID-19 pandemic | 83 |
| Deep vein thrombosis | 130 |
| Diastolic hypertension | 39 |
| Digital health | 83 |
| Dual protection | 200 |
| ECG | 169 |
| Echocardiography | 113, 207 |
| Electrocardiogram | 169 |
| Electrocardiography | 143 |
| Endovascular treatment | 136 |
| Experimental model | 150 |
| Gender | 169 |
| Healthcare | 83 |
| Heart failure | 9 |
| Heart rhythm | 185 |
| Hemostasis | 193 |
| HRV | 49 |
| Hypertension | 39 |
| Insulin resistance | 76 |
| Ischemia modified albumin | 19 |
| Isolated systolic hypertension | 39 |
| Krill oil | 150 |
| Left atrial diameter | 185 |
| Left atrial functions | 113 |
| Left atrial volume | 113 |
| Limb-salvage | 70 |
| Lipoma | 1 |
| Low molecular weight heparin | 130 |
| Malnutrition | 122 |
| Medical treatment | 130 |
| Microalbuminuria | 39 |
| Mortality | 122, 169 |
| Myocardial blush grade | 105 |
| Myocarditis | 207 |
| NT-proBNP | 185 |
| Off-pump coronary artery bypass | 19 |
| Omega-3 | 150 |
| P-wave dispersion | 143 |
| Patch closure | 179 |
| PATIMA index | 53 |
| Patient characteristic | 136 |
| Pediatrics | 61 |
| Percutaneous coronary intervention | 94 |
| Peripartum cardiomyopathy | 213 |
| peripheral arterial disease | 193 |
| Postoperative restenosis | 185 |
| Primary longitudinal arteriotomy closure | 179 |
| Prognosis | 9 |
| Pulse pressure | 39 |
| QTc interval | 105 |
| Resistance | 94 |
| Resistant hypertension | 185 |
| Restrictive cardiomyopathy | 213 |
| Rhabdomyosarcoma | 70 |
| Soft tissue sarcoma | 70 |
| ST-elevation myocardial infarction (STEMI) | 122 |
| ST-segment elevation myocardial infarction | 105 |
| ST-segment resolution | 105 |
| Stent | 61 |
| Stroke | 200 |
| Subclavian artery disease | 136 |
| Surgery | 61 |
| Surgical treatment | 1 |
| SYNTAX score | 53 |
| Telemedicine | 83 |
| Thyroiditis | 207 |
| Total serum protein (TSP) | 122 |
| Triglyceride glucose index | 76 |
| Upper extremity | 130 |
| Vascular closure device | 192, 193 |
| Vessel-sparing surgery | 70 |
| Visceral fat | 27 |
| Vitamin D | 158 |